Britannica Sources used in this answer

How did Sir James Black’s research lead to beta blockers?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Gleevec; imatinib — drug Docking of the anticancer drug Gleevec (imatinib) in the abl domain of the bcr-abl tyrosine kinase. Abnormalities in bcr-abl stimulate the continuous proliferation of bone marrow stem cells, causing an increase in myelogenous cells (granulocytes and macrophages) in the body and leading to chronic myelogenous leukemia (CML).

Sir James Black’s development of beta blockers was rooted in his systematic research into the interactions between cell receptors and chemicals in the bloodstream.1

Black sought a treatment for angina pectoris, a condition characterized by chest pain caused by the heart’s inability to receive sufficient oxygen. He understood that when epinephrine and norepinephrine stimulate beta receptors in the heart muscle, they increase the heart rate and the strength of contractions, thereby raising the organ's oxygen demand.1

To counter this, Black developed a drug designed to block these receptor sites. By preventing the hormones from attaching to the beta receptors, the drug inhibited their excitatory effects, effectively reducing the heart's demand for oxygen and relieving anginal pain. This breakthrough led to the creation of propranolol and paved the way for other beta-blocking agents used to treat conditions such as hypertension, migraines, and cardiac arrhythmias.12